NCT06759155View on ClinicalTrials.gov

Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
OPSCCOropharyngeal Squamous Cell Carcinoma (SCC)HPV Associated Cancers
Interventions
RADIATION

de-intensified radiation

Adjuvant radiation will be administered on a de-intensified schedule.

All Listed Sponsors
lead

University of Vermont Medical Center

OTHER